|
UBR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.994400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.528100000454E-07 |
| Normal-vs-Stage2 |
6.668400E-01 |
| Normal-vs-Stage3 |
9.845200E-01 |
| Normal-vs-Stage4 |
3.92510000000179E-05 |
| Stage1-vs-Stage2 |
2.217000E-01 |
| Stage1-vs-Stage3 |
2.235200E-01 |
| Stage1-vs-Stage4 |
4.469400E-01 |
| Stage2-vs-Stage3 |
6.932000E-01 |
| Stage2-vs-Stage4 |
1.477830E-01 |
| Stage3-vs-Stage4 |
1.234430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.740590E-03 |
| Normal-vs-AfricanAmerican |
4.036100E-02 |
| Normal-vs-Asian |
1.069210E-01 |
| Caucasian-vs-AfricanAmerican |
5.457600E-01 |
| Caucasian-vs-Asian |
7.378800E-01 |
| AfricanAmerican-vs-Asian |
9.698000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.220400E-04 |
| Normal-vs-Female |
2.241800E-01 |
| Male-vs-Female |
4.442200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.628000E-04 |
| Normal-vs-Extreme_Weight |
2.961000E-03 |
| Normal-vs-Obese |
7.017200E-01 |
| Normal-vs-Extreme_Obese |
2.300900E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.167400E-01 |
| Normal_Weight-vs-Obese |
1.265420E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.832800E-01 |
| Extreme_Weight-vs-Obese |
1.178830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.695800E-01 |
| Obese-vs-Extreme_Obese |
1.382020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.379400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.538100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.428090E-02 |
| Normal-vs-Age(81-100Yrs) |
4.95530000033106E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.786000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.362600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.447900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.584600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.935800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.542100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.98919999974778E-07 |
| Normal-VS-Type2 PRCC |
7.578400E-01 |
| Normal-VS-KIRP CIMP |
6.527400E-01 |
| Normal-VS-Unclassified PRCC |
8.822800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.278830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.056000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.603400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.445000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.855800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.680000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.506100E-02 |
| Normal-vs-N1 |
9.494400E-01 |
| Normal-vs-N2 |
1.65134572682746E-12 |
| N0-vs-N1 |
2.484600E-01 |
| N0-vs-N2 |
2.777600E-02 |
| N1-vs-N2 |
1.158320E-03 |
|
|
